Theravance Biopharma, Inc. Share Price & Technical Analysis
TBPH · $16.37 (+0.18%)
Healthcare / Biotechnology
$16.37
+0.18%
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic ne…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-2% return in May, -1% avg return in past 3 year May month.
-17% return in 2026, 20% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 1% | -5% | -13% | 2% | -2% | – | – | – | – | – | – | – | -17% |
| 25 | -1% | 2% | -4% | 10% | -7% | 10% | 2% | 25% | 5% | 1% | 37% | -7% | 74% |
| 24 | -14% | 0% | -6% | -7% | 2% | -2% | 19% | -20% | -1% | 1% | 8% | 3% | -16% |
| 23 | -4% | 0% | 1% | -1% | 3% | -7% | -4% | -4% | -10% | 9% | 12% | 8% | 2% |
| 22 | -19% | 12% | -4% | 0% | -9% | 3% | -3% | 2% | 13% | -1% | 7% | 6% | 8% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$848.05M
P/E ratio
7.38
52W high
$21.03
52W low
$9.10
Volume
2,77,609
Beta
0.19
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Theravance Biopharma, Inc. share price today?
- Theravance Biopharma, Inc. (TBPH) last traded around $16.37 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TBPH have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TBPH. Download the app for real-time alerts.
- How can I analyze Theravance Biopharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.